180 related articles for article (PubMed ID: 15158969)
21. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
22. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.
Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B
Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609
[TBL] [Abstract][Full Text] [Related]
23. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
24. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
25. Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.
Hu Z; Jiang X; Albright CF; Graciani N; Yue E; Zhang M; Zhang SY; Bruckner R; Diamond M; Dowling R; Rafalski M; Yeleswaram S; Trainor GL; Seitz SP; Han W
Bioorg Med Chem Lett; 2010 Feb; 20(3):853-6. PubMed ID: 20060717
[TBL] [Abstract][Full Text] [Related]
26. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
27. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model.
Kratz F; Roth T; Fichiner I; Schumacher P; Fiebig HH; Unger C
J Drug Target; 2000; 8(5):305-18. PubMed ID: 11328658
[TBL] [Abstract][Full Text] [Related]
29. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
[TBL] [Abstract][Full Text] [Related]
30. Polymeric anticancer drugs with pH-controlled activation.
Ulbrich K; Subr V
Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
[TBL] [Abstract][Full Text] [Related]
31. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
32. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract][Full Text] [Related]
33. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes.
Pan H; Han L; Chen W; Yao M; Lu W
J Control Release; 2008 Feb; 125(3):228-35. PubMed ID: 18022270
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy.
Lai PS; Lou PJ; Peng CL; Pai CL; Yen WN; Huang MY; Young TH; Shieh MJ
J Control Release; 2007 Sep; 122(1):39-46. PubMed ID: 17628166
[TBL] [Abstract][Full Text] [Related]
36. Polymeric micellar pH-sensitive drug delivery system for doxorubicin.
Hrubý M; Konák C; Ulbrich K
J Control Release; 2005 Mar; 103(1):137-48. PubMed ID: 15710507
[TBL] [Abstract][Full Text] [Related]
37. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
38. Zinc finger-inspired nanohydrogels with glutathione/pH triggered degradation based on coordination substitution for highly efficient delivery of anti-cancer drugs.
Zhang Z; Wan J; Sun L; Li Y; Guo J; Wang C
J Control Release; 2016 Mar; 225():96-108. PubMed ID: 26812007
[TBL] [Abstract][Full Text] [Related]
39. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
Greish K; Sawa T; Fang J; Akaike T; Maeda H
J Control Release; 2004 Jun; 97(2):219-30. PubMed ID: 15196749
[TBL] [Abstract][Full Text] [Related]
40. Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.
Soucek J; Poucková P; Zadinová M; Hlousková D; Plocová D; Strohalm J; Hrkal Z; Oleár T; Ulbrich K
Neoplasma; 2001; 48(2):127-32. PubMed ID: 11478693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
